Portola Pharmaceuticals to Announce First Quarter 2019 Financial Results on Wednesday, May 8, 2019
April 17 2019 - 4:15PM
Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that
it will host a webcast and conference call to discuss the Company’s
financial results for the quarter ended March 31, 2019, and provide
a general business overview on Wednesday, May 8, 2019,
at 8:30 a.m. ET (5:30 a.m. PT).
Conference Call DetailsThe live
conference call on Wednesday, May 8, 2019, at 8:30 a.m.
ET, can be accessed by phone by calling (844) 452-6828
from the United States and Canada or 1 (765)
507-2588 internationally and using the passcode 1684446. The
webcast can be accessed live on the Investor Relations section of
the Company's website at http://investors.portola.com. It will
be archived for 30 days following the call.
About Portola Pharmaceuticals,
Inc.Portola Pharmaceuticals is a commercial-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel therapeutics that could significantly
advance the fields of thrombosis and other hematologic diseases.
The Company’s two FDA-approved medicines are
Bevyxxa® (betrixaban), the first and only oral, once-daily
Factor Xa inhibitor for the prevention of VTE in adult patients
hospitalized for an acute medical illness, and
Andexxa® [coagulation factor Xa (recombinant),
inactivated-zhzo], the first and only antidote for the Factor Xa
inhibitors rivaroxaban or apixaban. The company also is advancing
cerdulatinib, a Syk/JAK inhibitor for the treatment of hematologic
cancers.
Investor Contact: |
Media Contact: |
Cara Miller |
Julie Normart |
Portola Pharmaceuticals |
Pure Communications |
ir@portola.com |
jnormart@purecommunications.com |
Portola Pharmaceuticals (NASDAQ:PTLA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Historical Stock Chart
From Sep 2023 to Sep 2024